Skip to main content
Journal cover image

The 2020 update of the CEAP classification system and reporting standards.

Publication ,  Journal Article
Lurie, F; Passman, M; Meisner, M; Dalsing, M; Masuda, E; Welch, H; Bush, RL; Blebea, J; Carpentier, PH; De Maeseneer, M; Gasparis, A; Uhl, JF ...
Published in: J Vasc Surg Venous Lymphat Disord
May 2020

The CEAP (Clinical-Etiology-Anatomy-Pathophysiology) classification is an internationally accepted standard for describing patients with chronic venous disorders and it has been used for reporting clinical research findings in scientific journals. Developed in 1993, updated in 1996, and revised in 2004, CEAP is a classification system based on clinical manifestations of chronic venous disorders, on current understanding of the etiology, the involved anatomy, and the underlying venous pathology. As the evidence related to these aspects of venous disorders, and specifically of chronic venous diseases (CVD, C2-C6) continue to develop, the CEAP classification needs periodic analysis and revisions. In May of 2017, the American Venous Forum created a CEAP Task Force and charged it to critically analyze the current classification system and recommend revisions, where needed. Guided by four basic principles (preservation of the reproducibility of CEAP, compatibility with prior versions, evidence-based, and practical for clinical use), the Task Force has adopted the revised Delphi process and made several changes. These changes include adding Corona phlebectatica as the C4c clinical subclass, introducing the modifier "r" for recurrent varicose veins and recurrent venous ulcers, and replacing numeric descriptions of the venous segments by their common abbreviations. This report describes all these revisions and the rationale for making these changes.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Vasc Surg Venous Lymphat Disord

DOI

EISSN

2213-3348

Publication Date

May 2020

Volume

8

Issue

3

Start / End Page

342 / 352

Location

United States

Related Subject Headings

  • Venous Insufficiency
  • Veins
  • Varicose Veins
  • Terminology as Topic
  • Severity of Illness Index
  • Prognosis
  • Predictive Value of Tests
  • Postthrombotic Syndrome
  • Humans
  • Evidence-Based Medicine
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lurie, F., Passman, M., Meisner, M., Dalsing, M., Masuda, E., Welch, H., … Wakefield, T. (2020). The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord, 8(3), 342–352. https://doi.org/10.1016/j.jvsv.2019.12.075
Lurie, Fedor, Marc Passman, Mark Meisner, Michael Dalsing, Elna Masuda, Harold Welch, Ruth L. Bush, et al. “The 2020 update of the CEAP classification system and reporting standards.J Vasc Surg Venous Lymphat Disord 8, no. 3 (May 2020): 342–52. https://doi.org/10.1016/j.jvsv.2019.12.075.
Lurie F, Passman M, Meisner M, Dalsing M, Masuda E, Welch H, et al. The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord. 2020 May;8(3):342–52.
Lurie, Fedor, et al. “The 2020 update of the CEAP classification system and reporting standards.J Vasc Surg Venous Lymphat Disord, vol. 8, no. 3, May 2020, pp. 342–52. Pubmed, doi:10.1016/j.jvsv.2019.12.075.
Lurie F, Passman M, Meisner M, Dalsing M, Masuda E, Welch H, Bush RL, Blebea J, Carpentier PH, De Maeseneer M, Gasparis A, Labropoulos N, Marston WA, Rafetto J, Santiago F, Shortell C, Uhl JF, Urbanek T, van Rij A, Eklof B, Gloviczki P, Kistner R, Lawrence P, Moneta G, Padberg F, Perrin M, Wakefield T. The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord. 2020 May;8(3):342–352.
Journal cover image

Published In

J Vasc Surg Venous Lymphat Disord

DOI

EISSN

2213-3348

Publication Date

May 2020

Volume

8

Issue

3

Start / End Page

342 / 352

Location

United States

Related Subject Headings

  • Venous Insufficiency
  • Veins
  • Varicose Veins
  • Terminology as Topic
  • Severity of Illness Index
  • Prognosis
  • Predictive Value of Tests
  • Postthrombotic Syndrome
  • Humans
  • Evidence-Based Medicine